Skip to main content

Advertisement

Table 2 Immunohistochemical staining for tumors stratified by anatomical sites

From: Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer

Variable All patients GB cancer Bile duct cancer p-value
  No. % No. % No. %  
P53 (n = 127)
   Positive 72 56.7 32 61.5 40 53.3 0.231
   Negative 55 43.3 20 38.5 35 46.7  
Cyclin D1 (n = 131)        
   Positive 35 26.7 18 33.3 17 22.1 0.109
   Negative 96 73.3 36 66.7 60 77.9  
Survivin (n = 129)        
   Positive 54 41.9 20 37.7 34 44.7 0.271
   Negative 75 58.1 33 62.3 42 55.3  
TP (n = 120)        
   Positive 78 65.0 40 78.4 38 55.1 0.006
   Negative 42 35.0 11 21.6 31 44.9  
ERCC1 (n = 113)        
   Positive 39 34.5 18 36.7 21 32.8 0.406
   Negative 74 65.5 31 63.3 43 67.2  
  1. GB, gallbladder; TP, thymidine phosphorylase; ERCC1, excision repair cross complementing protein 1